Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5695687 | Gynecologic Oncology | 2017 | 7 Pages |
Abstract
These findings, in aggregate, highlight the importance of communication with patients regarding prognosis, adverse effects and symptom management to help negotiate the decision making process. Chemotherapy in the recurrent setting should be managed on a case by case basis, combining both medical constraints and consideration to patient preferences.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
PEBC's Ovarian Oncology Guidelines Group PEBC's Ovarian Oncology Guidelines Group,